Recent Posts on This Topic | See All >
PathoGene exceeds initial financing goal and launches molecular diagnostics companyTags: genomics, northern arizona university, tgen
[Source: Pathogene] - PathoGene, LLC - a molecular diagnostics company located in Northern Arizona - has completed its first round of financing and raised 150% of its stated goal of $500K in seed money for a total of $750K. This new venture is being championed by top tier scientists, successful laboratory managers and experienced biotech executives who are using licensed technology from Northern Arizona University (NAU) and The Translational Genomics Research Institute (TGen) as a launching pad for building a successful bioscience business. During the financing period (April-July, 2010) Todd Snowden, President of PathoGene, was a featured speaker at the Southwest Bioscience Expo in Tucson, Arizona where he presented the business case for investing in PathoGene.
For more information: PathoGene Exceeds Initial Financing Goal and Launches Molecular Diagnostics Company
Now available: “Arizona’s Bioscience Roadmap 2014-2025: Advancing the Biosciences and Improving Health Outcomes,” is now available along with its supplement, “Summary of Goals, Strategies, and Potential Actions.” An overview by Walter Plosila, Ph.D., Battelle senior advisor, is also available. The updated Roadmap provides a long-term strategy for Arizona to achieve bioscience success over the next decade.